PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32703610-11	2021	PPARdelta agonists also reduce the NLRP3 inflammasome-associated neural inflammation in the MPTP PD model in mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	92-96	peroxisome proliferator activator receptor delta	Mus musculus	0-9	
23500098-0	2013	A peroxisome proliferator-activated receptor-delta agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson"s disease.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	91-135	peroxisome proliferator activator receptor delta	Mus musculus	2-50	
23500098-7	2013	Striatal PPARdelta levels were increased (over two-fold) immediately after MPTP treatment (30 mg/kg for 5 consecutive days) compared to saline-treated mice.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	75-79	peroxisome proliferator activator receptor delta	Mus musculus	9-18	
23500098-10	2013	These results indicate that agonism of PPARdelta provides protection against MPTP toxicity, in agreement with the effects of other PPAR agonists.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	77-81	peroxisome proliferator activator receptor delta	Mus musculus	39-48	
17167170-7	2007	Moreover, the PPARdelta agonists also significantly attenuated MPTP-induced depletion of striatal dopamine and related metabolite contents in mouse brain.	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	63-67	peroxisome proliferator activator receptor delta	Mus musculus	14-23